Luigi Bolondi - Concepedia

Author

Luigi Bolondi

Also Known As

A Cucchetti, Bolondi, L., Cavallari, Antonino, L BOLONDI, L Bolondi, L. BOLONDI, L. Bolondi, L., Bolondi, L.. Bolondi, LUIGI BOLONDI

517

Publications

40.7K

Citations

H-Index

127

Concepts

All Affiliations

University of Bologna IRCCS Azienda Ospedliero-Universitaria di Bologna Policlinico di Sant'Orsola Medica (Italy)Istituti di Ricovero e Cura a Carattere Scientifico University of Ferrara

About

Luigi Bolondi is an author at University of Bologna specializing in medicine, hepatology, and pathology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	46	97	10K
2	Health Sciences	24	42	3.1K
3	Engineering	5	5	510
4	Anatomy	4	4	166
5	Natural Sciences	1	1	21

Luigi Bolondi

191

Publications

35.7K

Citations

H-Index

Page 1

	Year	Citations
Sorafenib in Advanced Hepatocellular Carcinoma Josep M. Llovet, Sergio Ricci, Vincenzo Mazzaferro, New England Journal of Medicine	2008	12.8K
Cabozantinib in Patients with Advanced and Progressing Hepatocellular Carcinoma Ghassan K. Abou‐Alfa, Tim Meyer, Ann‐Lii Cheng, New England Journal of Medicine	2018	2.3K
Adjuvant sorafenib for hepatocellular carcinoma after resection or ablation (STORM): a phase 3, randomised, double-blind, placebo-controlled trial Jordi Bruix, Tadatoshi Takayama, Vincenzo Mazzaferro, The Lancet Oncology Surgical OncologyHepatologyMedicineSurgeryLiver Cancer	2015	1.1K
Hepatocellular carcinoma and cirrhosis in 746 patients: long-term results of percutaneous ethanol injection. Tito Livraghi, Antonio Giorgio, Gabriel Marín, Radiology	1995	941
Early occurrence and recurrence of hepatocellular carcinoma in HCV-related cirrhosis treated with direct-acting antivirals Fabio Conti, F. Buonfiglioli, Alessandra Scuteri, Journal of Hepatology HepatologyHepatitis CViral HepatitisHepatitisVirology	2016	888
Efficacy and safety of sorafenib in patients with advanced hepatocellular carcinoma: Subanalyses of a phase III trial Jordi Bruix, Jean‐Luc Raoul, Morris Sherman, Journal of Hepatology	2012	819
Cyclin G1 Is a Target of miR-122a, a MicroRNA Frequently Down-regulated in Human Hepatocellular Carcinoma Laura Gramantieri, Manuela Ferracin, Francesca Fornari, Cancer Research	2007	810
Guidelines and Good Clinical Practice Recommendations for Contrast Enhanced Ultrasound (CEUS) - Update 2008 M. Claudon, David O. Cosgrove, Thomas Albrecht, Ultraschall in der Medizin - European Journal of Ultrasound	2008	764
The safety of Sonovue® in abdominal applications: Retrospective analysis of 23188 investigations Fabio Piscaglia, Luigi Bolondi Ultrasound in Medicine & Biology Abdominal ApplicationsGastroenterologyRetrospective AnalysisSurgeryMedicine	2006	733
Surveillance programme of cirrhotic patients for early diagnosis and treatment of hepatocellular carcinoma: a cost effectiveness analysis Luigi Bolondi Gut	2001	643

Page 1